Renaud Prudent

Renaud Prudent is the Scientific Director of Biochemistry at EDELRIS and has over eight years of experience in kinase and cytoskeleton biochemistry, with a focus on drug discovery. They co-founded CELLIPSE SAS, where they served as Chief Operating Officer, aiming to develop innovative therapies for cancer patients. Renaud previously worked as a postdoctoral fellow at INSERM and held positions at CNRS and CEA, contributing to cellular screening, patent strengthening, and the development of new inhibitors. Renaud earned a PhD in Chemistry and Biology from Université Joseph Fourier (Grenoble I) and holds multiple degrees in biochemistry and chemical biology.